Bypass of Coronary Artery in Renal Artery Stenosis Patients with Heart Chronic Total Occlusion Might Explain the 5-Year Follow-Up after Percutaneous Coronary Intervention: B-RASHEF Study
Cardiorenal Medicine · 2024
DOI: 10.1159/000542449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Bin Zheng. Beteiligte Einrichtung: Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, …. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Renal Artery Obstruction, Coronary Occlusion. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Renal artery stenosis (RAS) is associated with poor outcome in patients with ischemic heart disease. In this study, we investigated the development of coronary collateral in RAS patients and possible association of RAS with a 5-year outcome after chronic total occlusion-percutaneous coronary intervention (CTO PCI).
Methods
Consecutive 58 patients with CTO PCI were enrolled prospectively, including 21 RAS patients (15 unilateral RAS and 6 bilateral RAS) and 37 non-RAS patients. RAS was diagnosed by renal duplex. Coronary collaterals were appraised by CC classification and Rentrop classification.
Results
Development of left anterior descending artery coronary collateral by Rentrop classification was significantly worse in RAS patients than non-RAS patients. Kaplan-Meier curve of survival was significantly worse in RAS patients than non-RAS patients (p = 0.027). By univariate COX proportional hazard regression analysis, collateral development by CC classification was a significant predictor for 5-year survival. When age, RAS, and collateral development by CC classification were included in multivariate COX proportional hazard regression analysis, only age (hazard ratio: 1.349; 95% confidential interval: 1.058–1.720; p = 0.016) and RAS (hazard ratio: 6.680; 95% confidential interval: 1.322–33.747; p = 0.022) were significant predictors for 5-year survival. Discussion/Conclusion: We concluded that survival in RAS patients after CTO PCI is significantly worse than non-RAS patients, and RAS is a significant predictor for survival after CTO PCI. It seems that injured collateral development might partly explain increased all cause death in RAS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Coronary Artery Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Zitieren
APA
Zheng, B. (2024). Bypass of Coronary Artery in Renal Artery Stenosis Patients with Heart Chronic Total Occlusion Might Explain the 5-Year Follow-Up after Percutaneous Coronary Intervention: B-RASHEF Study. Cardiorenal Medicine. https://doi.org/10.1159/000542449
Vancouver
Zheng B. Bypass of Coronary Artery in Renal Artery Stenosis Patients with Heart Chronic Total Occlusion Might Explain the 5-Year Follow-Up after Percutaneous Coronary Intervention: B-RASHEF Study. Cardiorenal Medicine. 2024. doi:10.1159/000542449
BibTeX
@article{Zheng2024,
author = {Zheng, Bin},
title = {Bypass of Coronary Artery in Renal Artery Stenosis Patients with Heart Chronic Total Occlusion Might Explain the 5-Year Follow-Up after Percutaneous Coronary Intervention: B-RASHEF Study},
journal = {Cardiorenal Medicine},
year = {2024},
doi = {10.1159/000542449}
}
EUVIMED